Multiplex RNA‐based detection of clinically relevant MET alterations in advanced non‐small cell lung cancer

Abstract excerpt

MET inhibitors have shown activity in non-small-cell lung cancer patients (NSCLC) with MET amplification and exon 14 skipping (METΔex14). However, patient stratification is imperfect, and thus, response rates have varied widely. Here, we studied MET alterations in 474 advanced NSCLC patients by nCounter, an RNA-based technique, together with next-generation sequencing (NGS), fluorescence in situ hybridization...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer Genomics and Diagnostics
• Share to Hepatocellular Carcinoma Treatment and Prognosis
• Share to Lung Cancer Treatments and Mutations